Putrajaya has entered an agreement to procure "breakthrough" COVID-19 drug Molnupiravir.
Health Minister Khairy Jamaluddin said in a statement today that the government has signed a letter of undertaking with Merck Sharp & Dohme, to buy 150,000 patient courses of the antiviral pill.
"Research by Merck Sharp & Dohme found that Molnupiravir can reduce hospitalisation and works against COVID-19 variants such as Gamma, Delta, and Mu," he added.
Molnupiravir can only be used to treat COVID-19 patients, and cannot be used for preventine purposes. Vaccines are still needed to reduce the risk of infection.
It works by introducing errors into the genetic code of the SARS-CoV-2 virus, which causes COVID-19, and has been hailed as a potential "breakthough" in the battle against the virus.
Several countries, including Singapore and Thailand, have already signed deals to purchase the pill, which is the first oral medication for COVID-19.
Molnupiravir is manufactured by Merck, a 130-year-old US-based multinational pharmaceutical company.
As of yesterday, more than 2.3 million people in the country have been stricken with COVID-19, and over 26,981 people have died from it.
The global coronavirus infection and death tally, meanwhile, has surpassed 237 million, and 4.84 million, respectively.
Photo source: Berita Harian.
Shuman
Thu Oct 07 2021


Dhee Full Interview I Saravedi Talk

Manmadha Bullets Reloaded I Episode 2

Exclusive Interview with Krish I Saravedi Night

Manmantha Bullets Reloaded I Episode 1

Bhagyalakshmi @ Suchitra I Full Interview I Saravedi Talk

Dato' Sri Siti Nurhaliza I Exclusive Interview | Astro Ulagam

Interview with Sri Nisha

Interview With Hari Priya

Kanna Murukku Thinna Aasaiya | Episode 5
What fate awaits Mama and the love-sick Jeeva? It’s time to find out!

Kanna Murukku Thinna Aasaiya | Episode 4
Grab your murukku because Mama is about to make a shocking discovery.